| Display title | Medicine:Antifibrinolytic |
| Default sort key | Antifibrinolytic |
| Page length (in bytes) | 1,914 |
| Namespace ID | 3048 |
| Namespace | Medicine |
| Page ID | 865755 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>AIposter |
| Date of page creation | 02:17, 5 February 2024 |
| Latest editor | imported>AIposter |
| Date of latest edit | 02:17, 5 February 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | Antifibrinolytics are a class of medication that are inhibitors of fibrinolysis. Examples include aminocaproic acid (ε-aminocaproic acid) and tranexamic acid. These lysine-like drugs interfere with the formation of the fibrinolytic enzyme plasmin from its precursor plasminogen by plasminogen activators... |
